ArticleScientific reports2026
Green mycosynthesis of a CuO/ZnO heterojunction nanocomposite using Aspergillus terreus and its antibacterial and anti-virulence activity against multidrug-resistant Escherichia coli.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rapid spread of multidrug-resistant (MDR) Escherichia coli poses a severe global health risk and demands the development of new antibacterial strategies. Biologically manufactured metal oxide nanocomposites have gained popularity due to their superior antibacterial activity and environmentally sustainable synthesis. This study uniquely integrates fungal metabolite profiling, green synthesis of a CuO/ZnO heterojunction nanocomposite, and molecular evaluation of anti-virulence activity against clinically isolated MDR Escherichia coli. The CuO/ZnO system was selected due to its synergistic heterostructure, which enhances reactive oxygen species generation and improves antibacterial performance compared to single metal oxides. In this investigation, an MDR E. coli strain was isolated from wound infections and identified using 16 S rRNA sequencing. A soil-derived fungus capable of forming CuO/ZnO nanocomposites was isolated and identified as Aspergillus terreus using 18 S rRNA sequencing. The bioactive constituents in the fungal filtrate were identified using High performance liquid chromatography (HPLC) and Gas chromatography-mass spectrometry (GC-MS). UV-Vis spectroscopy, transmission electron microscope (TEM), Fourier transform infrared spectroscopy(FTIR), and X-ray diffraction (XRD) were used to characterize the biosynthesized CuO/ZnO nanocomposite. The antibacterial effect against MDR E. coli was examined using disc diffusion and minimum inhibitory concentration (MIC) assays, and the influence on virulence and quorum-sensing genes was measured using quantitative reverse transcription PCR (qRT-PCR). The MDR E. coli isolate was resistant to all antibiotics tested. A variety of phenolic acids, flavonoids, and aromatic compounds were detected in the fungal filtrate; however, the filtrate alone did not exhibit antibacterial activity. The CuO/ZnO nanocomposite showed strong antibacterial activity, with an inhibition zone diameter of 2.3 ± 0.4 mm and MIC of 62.5 ± 0.2 µg/mL. Gene expression analysis indicated considerable downregulation of critical virulence genes, including fimH, luxS, toxA, and papC, suggesting impairment of adhesion, toxin synthesis, and quorum sensing. The biosynthesized CuO/ZnO nanocomposite shows strong antibacterial and anti-virulence activity against MDR E. coli, indicating its potential as an alternative antibacterial agent.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.